Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 27, 2015 8:42 AM ET


Company Overview of Emerillon Therapeutics Inc.

Company Overview

Emerillon Therapeutics, Inc., a biotechnology company, engages in the discovery and development of genomics-based drugs for infectious diseases. The company, through its recombinant congenic strains (RCS) mouse platform technology, discovers and develops drugs for human complex diseases. Its RCS mouse platform focuses on identifying drug targets in the fields of pain, atherosclerosis, osteoporosis, and epilepsy. Emerillon Therapeutics also offers contract services, such as mutation detection using dHPLC, mouse genotyping, and speed congenesis. The company was founded in 2003 and is based in Montréal, Canada.

416 de Maisonneuve West

Suite 1000

Montréal, QC H3A 1L2


Founded in 2003





Key Executives for Emerillon Therapeutics Inc.

Chief Executive Officer
Founder, President and Chief Scientific Officer
Director of Research and General Manager
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
ERAD Therapeutics Inc. Americas
URRMA Biopharma Americas
Mimetogen Pharmaceuticals Inc. Americas
Medicago Inc. Americas
AbCelex Technologies Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Emerillon Therapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at